Hospitals can use the Fresenius KRT analytics platform to analyze kidney therapy data, uncover trends, and improve program management.

Hospitals that provide kidney replacement therapy (KRT) in intensive care units collect huge amounts of data every day. While this information can offer valuable insights, it is often difficult to organize and analyze, hence Fresenius Medical Care has launched the Fresenius KRT analytics platform, called TherapyWise, a new cloud-based tool designed to help hospitals better understand how their KRT programs are performing.

The platform is available through NxView 4.0, Fresenius Medical Care’s FDA-cleared software used with the NxStage System One. Instead of focusing on individual patients in real time, TherapyWise looks at larger trends across a hospital’s kidney replacement therapy program, helping care teams review performance over weeks, months, or even longer.

A Smarter Way to Make Sense of KRT Data

Kidney replacement therapy is a complex treatment and every session generates a significant amount of clinical and operational data. For many hospitals, finding meaningful patterns in all that information can be time consuming. TherapyWise brings that data together in one place. It collects information from therapy sessions and medical devices, then turns it into understandable summaries.

The platform can highlight issues such as workflow interruptions, frequent machine alarms and differences in how therapy is delivered across departments or time periods.

Joe Turk, Chief Executive Officer of Care Enablement at Fresenius Medical Care, said:

“Digital solutions play an increasingly important role in how critical care teams understand and manage complex therapies. TherapyWise reflects our continued focus on innovation in critical care by applying data analytics.”

According to the company, the goal is to give healthcare teams a clearer picture of what is happening across their KRT programs so they can have more informed discussions about efficiency, consistency, and quality improvement.

Can Data Help Hospitals Improve Care Programs?

The platform shows metrics such as the average delivered dose compared with the prescribed dose, treatment time per cartridge, and trends in alarm frequency.

Data from the NxStage System One is securely sent to the cloud-based platform, where it is organized and analyzed. However, Fresenius Medical Care stresses that TherapyWise is not designed to make treatment decisions for individual patients. Those decisions continue to be made by doctors and clinical staff.

Instead, the platform serves as a management tool that helps hospitals review how their overall programs are functioning and identify areas that may need attention.

Part of a Larger Digital Healthcare Strategy

As far as Business Fortune observes, TherapyWise is the latest addition to Fresenius Medical Care’s growing portfolio of digital healthcare solutions. The company combines medical technology, secure data management, and clinical expertise to support healthcare providers treating patients with kidney disease. As hospitals continue to generate more healthcare data than ever before, tools like TherapyWise could become increasingly important.

 

FAQs

What is TherapyWise?

TherapyWise is a cloud-based analytics tool from Fresenius Medical Care that helps hospitals review and understand trends in kidney replacement therapy programs.

What kind of information does the platform analyze?

It analyzes therapy and device data, including treatment times, delivered doses, workflow interruptions, and alarm frequency trends.

Does TherapyWise make treatment decisions for patients?

No. The platform is only used for reviewing historical program data. Patient care decisions are still made by healthcare professionals.

How does TherapyWise receive its data?

The platform securely collects data from the NxStage System One through the NxView 4.0 software system.

Why is this platform important for hospitals?

It helps hospitals identify trends, improve workflows, monitor consistency, and support quality improvement efforts across their kidney replacement therapy programs.